Fund/Build/Scale

Thanks to AI, you could have an idea for a startup on your way home from work Thursday and finish a rough prototype by Monday morning.

That's great news for founders, but it also raises the bar: if everyone can build a convincing demo, what actually separates a durable company from a clever prototype?

To explore that question in depth, I interviewed Alex Niehenke a partner at Scale Venture Partners since 2012. He invests in early-stage companies tackling complex industries like insurance, wealth management, construction, and logistics.

We discuss why product innovation has to be paired with distribution innovation, how he judges your TAM estimate, how founders create entirely new categories, and what investors are looking for now that building software has never been easier.

RUNTIME 41:43
 

EPISODE BREAKDOWN
(02:58) Overview: Scale Venture Partners

(04:42) What Makes Slow-Moving Markets Attractive?

(06:19) Product Innovation Needs Go-to-Market Innovation

(08:58) Why TAM Is Really a Test of Strategic Thinking

(12:03) At Least Two-Thirds of My Investments Are Category Creation

(15:54) What Founder-Market Fit Means in the AI Era

(21:41) What Makes a Vertical AI Startup Fundable?

(24:52) What Separates a Nice Demo from a Durable Business?

(27:11) Selling Into Hard Markets

(33:03) When Regulation Becomes a Competitive Advantage

(34:52) Founder-Led Go-to-Market Wins Early

(37:01) Why Obsession Still Matters Most

LINKS

Alex Niehenke

Scale Venture Partners

Tessa Lau, CEO/Founder, Dusty Robotics

Deep Tech Without Stealth: Inside Dusty Robotics’ Origin Story, Fund/Build/Scale

Root Insurance

Motive

Shoe Dog, Phil Knight

Building something that’s hard to explain?
That’s often a sign you’re working on something interesting. It can also cost you fundraising, sales, hiring, and media opportunities.

I help early-stage founders sharpen the narrative around what they’re building: what matters, why now, who needs to care, and why they’re the right team to make it happen.

If you’re preparing for a raise, launch, important customer meeting, panel, or hiring push, I can help you pressure-test the story before the stakes get higher.

👉🏾 Learn more

SUBSCRIBE
📥 Get the Fund/Build/Scale newsletter on Beehiiv: https://fundbuildscale.beehiiv.com/

📸 Follow Fund/Build/Scale on Instagram: https://www.instagram.com/fundbuildscale/

📺 Watch Fund/Build/Scale on YouTube: https://www.youtube.com/channel/UCFFH4cs2B1BKatPGs8SFRJw

A lot of founders assume raising venture capital is just part of the process: you have an idea, build a deck, find some investors and start pitching. But what if you don't actually need the money yet?

Elia Wallen is the founder and CEO of Engine, a business travel platform valued at $2 billion. He bootstrapped his first company and resisted raising outside capital for Engine until the business was growing faster than he could support on his own.

In this episode, we talk about why raising too much money too soon can lead founders astray, how to tell the difference between needing capital and craving validation, why early-stage equity may be the most expensive money you'll ever raise, and how to know when your company is actually ready to start talking to investors.

We also get into the risks of letting investors steer a company before product-market fit, why founders should pressure-test how much money they really need, what Elia means by having "conviction with rationale," and why the opportunity should be pulling you forward before you raise.

RUNTIME 35:13
 

EPISODE BREAKDOWN
(1:40) What is Engine?

(3:25) Why ignorance can be an advantage

(5:38) Are you raising money for validation?

(8:58) What constraint teaches founders

(10:57) How much money do you actually need?

(17:44)When it actually makes sense to raise

(21:18) How investors can pull you off course 

(26:38) Equity is more expensive than you think

(30:55) How to know when you're ready to raise

LINKS

Elia Wallen

Engine

The Case for Raising Less Money Than You Can, Inc.com

Building something that’s hard to explain?
That’s often a sign you’re working on something interesting. It can also cost you fundraising, sales, hiring, and media opportunities.

I help early-stage founders sharpen the narrative around what they’re building: what matters, why now, who needs to care, and why they’re the right team to make it happen.

If you’re preparing for a raise, launch, important customer meeting, panel, or hiring push, I can help you pressure-test the story before the stakes get higher.

👉🏾 Learn more

SUBSCRIBE
📥 Get the Fund/Build/Scale newsletter on Beehiiv: https://fundbuildscale.beehiiv.com/

📸 Follow Fund/Build/Scale on Instagram: https://www.instagram.com/fundbuildscale/

📺 Watch Fund/Build/Scale on YouTube: https://www.youtube.com/channel/UCFFH4cs2B1BKatPGs8SFRJw

Most startup fundraising advice focuses on how to get investors interested.

Ryan Ziegler sees the process from the other side of the table.

As a General Partner at Edison Partners, Ryan evaluates startups that have already survived one of the hardest phases of company building: finding customers willing to pay for what they've built. 

By the time founders reach him, the question is no longer whether the idea is interesting. It's whether the business is repeatable.

In this episode, Ryan explains why most startups shouldn't raise money even if they can, how investors separate durable customer demand from vanity metrics, what actually makes a company ready for Series A, and why founder self-awareness may matter more than a perfect pitch deck.

We also discuss customer reference calls, leadership scorecards, founder coachability, and why companies need an operating system before they try to grow.

RUNTIME 45:29
 

EPISODE BREAKDOWN
(2:37) How Edison Partners Finds Bootstrapped Companies Ready to Scale

(5:40) Why Most Startups Shouldn't Raise Money (Even If They Can)

(11:39) How Venture Capital Can Create False Signals About Product-Market Fit

(19:49) What Series A Readiness Actually Looks Like

(25:01) The Difference Between Real Customer Demand and Fundraising Theater

(27:35) Founder Transparency, Investor Trust, and Long-Term Partnerships

(33:32) Why Coachability Beats Founder Ego

(35:45) Building an Operating System That Scales Beyond the Founder

(38:21) A Practical Series A Readiness Self-Audit

LINKS
Ryan Ziegler

Edison Partners

SUBSCRIBE
📥 Get the Fund/Build/Scale newsletter on Beehiiv: https://fundbuildscale.beehiiv.com/

📸 Follow Fund/Build/Scale on Instagram: https://www.instagram.com/fundbuildscale/

📺 Watch Fund/Build/Scale on YouTube: https://www.youtube.com/channel/UCFFH4cs2B1BKatPGs8SFRJw

Conventional wisdom says the hardest part of building a startup is building the product.

Shanea Leven says the harder challenge is figuring out what customers will actually pay for.

Before co-founding Empromptu.ai, Shanea spent more than 15 years building products at companies including Google, eBay, Docker, and Cloudflare.

In this conversation, she explains why sales is every bit as complex as engineering, why customer interviews aren't enough to validate an idea, and why early-stage founders need to spend more time testing demand than perfecting roadmaps.

We discuss the case-study approach she uses to find customers, the controversial belief that the only real product validation is money, and what happened when a LinkedIn post generated a 1,000-person waitlist almost overnight. 

Shanea also shares how she used more than 100 customer calls to shape Empromptu’s direction, why she stopped fundraising when the company took  off, and the go-to-market challenges that still keep her up at night.

If you're a technical founder trying to figure out whether you're building something people truly want, this episode offers a practical framework for separating genuine demand from wishful thinking.

Listen to this episode if you're trying to figure out:

why sales validation should happen before you commit to a roadmap

how to find your first customers using the case study method

what a viral waitlist can teach you about product-market fit

how to distinguish customer feedback from customer demand

why technical founders need to learn sales earlier than they think

which early traction signals are worth trusting — and which aren't

how to validate an idea before spending months building it

RUNTIME 49:06
 

EPISODE BREAKDOWN
(3:16) What Is Empromptu.ai, and Who Is it For?

(6:25) Sales Is Just as Complicated as Engineering

(8:14) The Case Study Method for Finding Early Customers

(11:56) Why Al Is Rewriting the Product Playbook

(13:37)   The Only Real Product Validation Is Money 

(17:10) The S***ty Purple Website That Predicted Impromptu's Viral Launch

(21:38) What 100 Waitlist Calls Taught Shanea About Customer Demand

(26:28) "We evolved the platform."

(34:57) "Ninety-nine percent of VCs are great at one thing."

(36:20) The GTM Problem That Still Keeps Shanea Up at Night 

(39:02) A Process for Selecting Your First Sales/Marketing Hires

(40:59) Why She'd Hire a "Scrappy" Marketer Over a Former Meta Employee "Every Time"

(44:05) The Early Traction Signal She No Longer Trusts

(45:28) A 30-day Experiment Founders Can Run To Validate Their Idea

LINKS
Shanea Leven

Empromptu.ai

Empromptu raises $2M pre-seed to help enterprises build AI apps, 12/9/2025, TechCrunch

SUBSCRIBE
📥 Get the Fund/Build/Scale newsletter on Beehiiv: https://fundbuildscale.beehiiv.com/

 

📸 Follow Fund/Build/Scale on Instagram: https://www.instagram.com/fundbuildscale/

 

📺 Watch Fund/Build/Scale on YouTube: https://www.youtube.com/channel/UCFFH4cs2B1BKatPGs8SFRJw

 

Thanks for listening!

 – Walter

If you're building a startup, there are easier industries to choose than healthcare.

Sales cycles are long, regulations are complex, and earning the trust of providers and patients takes years.

In this episode, Mayo Clinic Platform Accelerate Director Jamie Sundsbak explains how healthtech founders can improve their odds of success.

We discuss what Mayo looks for in founding teams, why the program focuses on product development instead of fundraising, how startups use clinical data and physician feedback to refine AI products, and what healthcare systems are actually buying in today's market.

Jamie also shares lessons from reviewing hundreds of startup applications, the founding team profiles that stand out, why some companies gain traction while others stall, and what founders should know before building in one of the world's most regulated industries.

Listen to this episode if you're trying to figure out:

What Mayo Clinic looks for in healthtech founders

How to use customer feedback to improve AI products

Why some healthcare startups gain traction while others struggle

What health systems are actually buying in the AI boom

How to navigate the long road from MVP to clinical adoption

Watch on YouTube: https://youtu.be/whrR0IVHEOY

RUNTIME 38:35
 

EPISODE BREAKDOWN
(1:39) What Mayo Clinic Looks for in Early-Stage Healthtech Startups

(13:31) How Mayo Uses Clinical Data and Physician Feedback to Improve Products

(23:50) The Art of Creating Provider FOMO

(25:32) The Ideal Healthtech Founding Team

(29:29) Why OpenEvidence Won — and What Hospitals Are Buying Today

(36:03) Healthcare Is Hard. Here's Why Founders Keep Choosing It Anyway

LINKS

Jamie Sundsbak

Mayo Clinic Platform Accelerate

Most U.S. doctors are quietly using this AI tool. Few patients know about it, NBC News, 5/13/2026

SUBSCRIBE
📥 Get the Fund/Build/Scale newsletter on Beehiiv: https://fundbuildscale.beehiiv.com/

📸 Follow Fund/Build/Scale on Instagram: https://www.instagram.com/fundbuildscale/

📺 Watch Fund/Build/Scale on YouTube: https://www.youtube.com/channel/UCFFH4cs2B1BKatPGs8SFRJw

 

Thanks for listening!

 – Walter